Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Not Confirmed
Not Confirmed
24-27 July, 2025
KY/TN Water Profession...KY/TN Water Professionals
Not Confirmed
Not Confirmed
27-30 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Industry Trade Show
Not Confirmed
24-27 July, 2025
KY/TN Water Profession...KY/TN Water Professionals
Industry Trade Show
Not Confirmed
27-30 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
27 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250627745465/en/Exicure-Inc.-Reports-First-Quarter-2025-Financial-Results
28 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250528272971/en/Exicure-Inc.-Received-Nasdaq-Delinquency-Notice-on-Late-Filing-of-its-Form-10-Q
05 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250505513656/en/Exicure-Completes-Patient-Enrollment-in-Phase-2-Study-of-GPC-100-for-Stem-Cell-Mobilization-in-Multiple-Myeloma-Patients-Undergoing-Autologous-Transplant
14 Apr 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250414193932/en/Exicure-Inc.-Nasdaq-XCUR-Nears-Completion-of-Phase-2-Study-of-GPC-100-in-Multiple-Myeloma
11 Apr 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250411634017/en/Exicure-Inc.-Nasdaq-XCUR-Announces-Their-Next-Step-in-Planning-for-a-New-Clinical-Trial-in-Acute-Myeloid-Leukemia-AML
18 Mar 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250318788523/en/Exicure-Inc.-Reports-Full-Year-2024-Financial-Results
ABOUT THIS PAGE